| 摘要 |
The invention relates to new morpholines and morpholine-N-oxides of formula <IMAGE> (I) wherein the substituents are defined hereunder, which compounds have valuable pharmacological properties, namely an effect on the metabolism, preferably the effect of lowering blood sugar and reducing body fat, and the effect of lowering the atherogenic beta -lipoproteins VLDL and LDL, and a performance enhancing effect in animals.
|
